For long-term storage, it is recommended to use -80°C glycerol freezing storage. Specific procedure: mix the library yeast culture with sterile glycerol at a 4:1 volume ratio (final glycerol concentration 20%), aliquot into sterile cryovials (1-2 mL per vial), and quickly place them in a -80°C freezer (avoid gradient cooling to prevent ice crystal damage to yeast cells). Three key points require attention:

1.Before aliquoting, ensure the yeast is in the logarithmic growth phase (OD600 ≈ 0.8-1.0), as cells have the highest vitality at this stage, achieving a post-thaw recovery rate of over 80%;

2.Avoid repeated freeze-thaw cycles. Immediately return vials to -80°C after use. If frequent access is needed, prepare multiple aliquots;

Perform recovery every 6-12 months. Inoculate the yeast into YPD medium for culture and then re-freeze. This prevents gene mutations or plasmid loss during extended storage, which could lead to a decline in library diversity.

Multiple controls and gradient validation experiments can be set up to differentiate:

(i) Include an "Empty Vector Yeast Control":
Transform yeast with the linearized vector lacking the insert gene. After incubation with the antigen, perform FACS detection. Its fluorescence signal value serves as a baseline threshold for false positives; only clones exceeding this threshold proceed to subsequent validation;

(ii) Conduct a "Competitive Binding Assay":
Add an excess of unlabeled soluble antigen to the screening system. If the clone's fluorescence signal decreases significantly (reduction ≥ 50%), it indicates specific binding, confirming a true positive;

(iii) Perform "Gradient Antigen Concentration Screening":
Incubate clones with 3-5 gradient concentrations of antigen. True positive clones will show a clear increasing trend in fluorescence signal with rising antigen concentration, whereas false positive signals will be irregular or non-increasing, allowing further exclusion of non-specific binding clones.

Two main challenges are faced:
(i) The hydrophobic transmembrane domains of membrane proteins tend to aggregate inside yeast cells, leading to low surface display efficiency and potentially impairing yeast cell viability;

(ii) Membrane proteins often require specific co-factors (e.g., cholesterol, glycosylation modifications) to form correct conformations. The yeast modification system might be insufficient, resulting in displayed proteins lacking binding activity.

Countermeasures:
(i) Engineer the yeast surface display vector:
Insert a flexible linker (e.g., (Gly4Ser)3) between the membrane protein gene and the anchor protein (Aga2p) to reduce steric hindrance from the transmembrane domain. Also, include an endoplasmic reticulum signal peptide in the vector to guide correct membrane protein trafficking to the cell membrane

(ii) Optimize the yeast culture environment:
Add appropriate cholesterol (e.g., 10 μg/mL) to the medium, or select yeast strains capable of complex glycosylation modifications (e.g., Pichia pastoris GS115) to supplement the co-factors required for membrane protein conformation;

Reduce membrane protein expression levels:
Weaken promoter strength (e.g., replace the GAL1 promoter with the GAL10 promoter) to avoid excessive protein aggregation and improve display efficiency.

Four core validation experiments are required:

(i) "Plasmid Extraction and Sequencing Validation":
Extract plasmids from positive clones and perform Sanger sequencing to confirm the correct target gene sequence, absence of frameshift mutations or base deletions, and rule out gene sequence abnormalities caused by PCR amplification or homologous recombination;

(ii) "Protein Expression Verification":
Detect yeast cell membrane protein extracts via Western blot using antibodies against the anchor protein (e.g., Aga2p) or the target protein tag (e.g., c-Myc). This confirms successful surface expression of the target protein on yeast, avoiding "false positives" stemming from non-specific signals generated despite lack of gene expression;

(iii) "In Vitro Binding Activity Quantitative Verification":
Employ ELISA: coat the antigen on an ELISA plate, add positive clone culture, and quantitatively calculate binding affinity (KD value) by detecting fluorescence or enzymatic activity signals. This confirms the binding capability meets experimental requirements;

"Functional Validation Experiment" (dependent on research objectives):
For antibody clones, neutralization activity assays (detecting inhibition effects on pathogens) are needed; for enzyme clones, enzyme activity assays are required. This ensures positive clones not only bind the target molecule but also possess the expected biological function, providing a basis for subsequent applications.